SCHEMBL3020751

SCHEMBL3020751

O=C(CC/C=C/c1ccccc1)CC/C=C/c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAM P19021 2/20 0.59
HDAC3 O15379 3/20 0.53
HDAC4 P56524 3/20 0.53
HDAC1 Q13547 3/20 0.53
HDAC2 Q92769 3/20 0.53
HDAC8 Q9BY41 3/20 0.53
HDAC6 Q9UBN7 3/20 0.53
HDAC7 Q8WUI4 2/20 0.53
HDAC10 Q969S8 2/20 0.53
HDAC11 Q96DB2 2/20 0.53
HDAC9 Q9UKV0 2/20 0.53
HDAC5 Q9UQL6 2/20 0.53
MAOB P27338 2/20 0.49
ALDH1A1 P00352 2/20 0.48
PLIN1 O60240 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
RECQL P46063 2/20 0.48
PLIN5 Q00G26 2/20 0.48
ABHD5 Q8WTS1 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6064354 1.00 PAM (0.59) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL28158290 0.93 PAM (0.52) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL29067636 0.90 PAM (0.53) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL11155173 0.89 GPR52 (0.50) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL2308813 0.89 PAM (0.52) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL2308808 0.89 PAM (0.52) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL7112361 0.88 PAM (0.55) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL666894 0.88 PAM (0.64) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL1231739 0.88 PAM (0.64) PAMHDAC3HDAC4HDAC1HDAC2
SCHEMBL1232837 0.88 PAM (0.64) PAMHDAC3HDAC4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130273798-A1 ANTI-ALLERGEN AGENT TOAGOSEI CO., LTD. (JP) 2013-10-17 US disclosed
US-20100209530-A1 ANTI-ALLERGEN AGENT TOAGOSEI CO., LTD. (JP) 2010-08-19 US disclosed
EP-1754700-A2 Synthesis of oligoketides Kosan Biosciences, Inc. (US) 2007-02-21 EP disclosed
US-7022825-B2 Polyketides and antibiotics KOSAN BIOSCIENCES, INC. (US) 2006-04-04 US disclosed
EP-1471923-A4 AMIDO MACROLIDES KOSAN BIOSCIENCES INC (US) 2006-01-11 EP disclosed
US-6939861-B2 Amido macrolides KOSAN BIOSCIENCES, INC. (US) 2005-09-06 US disclosed
EP-1471923-A1 AMIDO MACROLIDES Kosan Biosciences, Inc. (US) 2004-11-03 EP disclosed
US-20030199458-A1 Amido macrolides KOSAN BIOSCIENCES, INC. 2003-10-23 US disclosed
EP-0794218-B1 Polycarbonate resin composition stabilized against radiation MITSUBISHI ENG PLASTICS CORP (JP) 2003-10-15 EP disclosed
WO-2003061671-A1 AMIDO MACROLIDES KOSAN BIOSCIENCES, INC. (US) 2003-07-31 WO disclosed
US-20030092140-A1 Novel polyketides and antibiotics ASHLEY GARY (US) 2003-05-15 US disclosed
EP-1144375-A2 SYNTHESIS OF OLIGOKETIDES Kosan Biosciences (US) 2001-10-17 EP disclosed
WO-2000044717-A9 SYNTHESIS OF OLIGOKETIDES 2001-08-23 WO disclosed
WO-2000044717-A2 SYNTHESIS OF OLIGOKETIDES KOSAN BIOSCIENCES, INC. (US) 2000-08-03 WO disclosed
US-6040367-A EXCELLENT RESISTANCE TO AN IONIZING RADIATION, IN WHICH HETEROCYCLIC COMPOUND CONTAINING OXYMETHYLENE UNITS MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) 2000-03-21 US disclosed
US-5948838-A 0.01 TO 5 PARTS BY WEIGHT OF A COMPOUND CONTAINING OXYMETHYLENE UNIT MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) 1999-09-07 US disclosed
EP-0794218-A2 Polycarbonate resin composition stabilized against radiation MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) 1997-09-10 EP disclosed
US-5360775-A Porous clay intercalation compound and its production method MITSUBISHI MATERIAL CORPORATION (JP) 1994-11-01 US disclosed
US-5013709-A Acid-treated smectite clay mineral MIZUSAWA INDUSTRIAL CHEMICALS, LTD. (JP) 1991-05-07 US disclosed
US-4709024-A REARRANGEMENT OF CYCLOHEXANONE OXIME SUMITOMO CHEMICAL COMPANY (JP) 1987-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199458-A1 Amido macrolides PCSK9, ABCB4, PCSK7 PAM 73/4885HDAC3 221/4885HDAC4 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.